Company registration number 14146177 (England and Wales)
RAYLEIGH EYECARE LTD
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
PAGES FOR FILING WITH REGISTRAR
RAYLEIGH EYECARE LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
RAYLEIGH EYECARE LTD
BALANCE SHEET
AS AT 31 AUGUST 2025
31 August 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
4,333
4,583
Tangible assets
4
25,859
29,907
30,192
34,490
Current assets
Stocks
50,213
36,453
Debtors
5
21,589
55,004
Cash at bank and in hand
221,590
237,400
293,392
328,857
Creditors: amounts falling due within one year
6
(243,949)
(268,338)
Net current assets
49,443
60,519
Total assets less current liabilities
79,635
95,009
Provisions for liabilities
(5,168)
(5,896)
Net assets
74,467
89,113
Capital and reserves
Called up share capital
7
50
50
Capital redemption reserve
50
50
Profit and loss reserves
74,367
89,013
Total equity
74,467
89,113
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 7 October 2025 and are signed on its behalf by:
Mr B Gallagher
Director
Company registration number 14146177 (England and Wales)
RAYLEIGH EYECARE LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
- 2 -
1
Accounting policies
Company information
Rayleigh Eyecare Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 85 High Street, Rayleigh, SS6 7EJ.
1.1
Reporting period
The financial statements cover a 52-week period and are therefore not directly comparable with the prior year, which spans 61 weeks.
1.2
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.3
Turnover
Turnover represents amounts receivable for goods and services provided in the normal course of business, net of trade discounts, VAT and other sales-related taxes.
Turnover is recognised as earned when, and to the extent that, the company obtains the right to consideration in the
exchange for goods and services provided.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is
probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
Revenue from the provision of optometry services is recognised when the service is provided.
1.4
Intangible fixed assets other than goodwill
Intangible assets relate to a franchise fee paid and measured at cost less accumulated amortisation.
Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Patents & licences
5% on cost
1.5
Tangible fixed assets
Tangible fixed assets are measured at cost, net of depreciation.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and equipment
20% reducing balance
Fixtures and fittings
20% reducing balance
Computers
20% reducing balance
RAYLEIGH EYECARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 3 -
1.6
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.
Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.7
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Debtors and creditors with no stated interest rate an receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.
1.8
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
RAYLEIGH EYECARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 4 -
1.9
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
16
17
3
Intangible fixed assets
Patents & licences
£
Cost
At 1 September 2024 and 31 August 2025
5,000
Amortisation and impairment
At 1 September 2024
417
Amortisation charged for the year
250
At 31 August 2025
667
Carrying amount
At 31 August 2025
4,333
At 31 August 2024
4,583
RAYLEIGH EYECARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 5 -
4
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Computers
Total
£
£
£
£
Cost
At 1 September 2024
16,447
2,698
19,796
38,941
Additions
2,187
2,187
At 31 August 2025
16,447
2,698
21,983
41,128
Depreciation and impairment
At 1 September 2024
2,879
789
5,366
9,034
Depreciation charged in the year
2,714
382
3,139
6,235
At 31 August 2025
5,593
1,171
8,505
15,269
Carrying amount
At 31 August 2025
10,854
1,527
13,478
25,859
At 31 August 2024
13,568
1,909
14,430
29,907
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
12,702
15,201
Other debtors
8,887
39,803
21,589
55,004
6
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
106,773
122,563
Corporation tax
98,261
128,557
Other taxation and social security
10,152
7,007
Other creditors
28,763
10,211
243,949
268,338
RAYLEIGH EYECARE LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 6 -
7
Called up share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
50
50
50
50
8
Parent company
The Company is jointly owned by Square Eyecare Limited and Oculus Prudentia Limited, each holding 50% of the issued ordinary share capital. There is no agreement or arrangement that grants either shareholder the ability to exercise overall control. Accordingly, in the opinion of the directors, the Company is not controlled by any one party. The ultimate controlling parties are therefore Square Eyecare Limited and Oculus Prudentia Limited together.
9
Related party transactions
During the year, the company loaned money from Square Eyecare Limited, a company that owns 50% of the ordinary share capital of Rayleigh Eyecare Ltd. At the year end, the amount owed to Square Eyecare Limited was £4,147 (2024 - £7,617) this amount is included in creditors: amounts falling due within one year.
10
Directors' transactions
Dividends totalling £41,000 (2024 - £201,000) were paid in the year in respect of shares held by the company's directors.
Advances or credits have been granted by the company to its directors as follows:
Description
% Rate
Opening balance
Amounts advanced
Amounts repaid
Closing balance
£
£
£
£
Directors' Loan
-
30,316
36,027
(72,493)
(6,150)
30,316
36,027
(72,493)
(6,150)